Liposome-based anchoring and core-encapsulation for combinatorial cancer therapy
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Smart liposomes that have been functionally changed are sensitive to a variety of internal and external stimuli, such as enzyme transformations, pH changes, redox reactions, microwaves, ultrasound, and light.
“Smart liposomes that have been functionally changed are also sensitive to a variety of internal and external stimuli, such as enzyme transformations, pH changes, redox reactions, microwaves, ultrasound, and light.50,51”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [51]
Cites
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 7,295 · see citing works
Cancer statistics for the year 2020: An overview
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021) · International Journal of Cancer · doi:10.1002/ijc.33588 · Cited by 5,963 · see citing works
Emerging roles of caspase-3 in apoptosis
Porter, A. G., & Jänicke, R. U. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400476 · Cited by 3,870 · see citing works
Szoka, F. C., & Papahadjopoulos, D. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4194 · Cited by 2,333 · see citing works
Jares-Erijman, E. A., & Jovin, T. M. (2003) · Nature Biotechnology · doi:10.1038/nbt896 · Cited by 1,830 · see citing works
Fluorescence resonance energy transfer
Clegg, R. M. (1995) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(95)80016-6 · Cited by 932 · see citing works
Survivin, versatile modulation of cell division and apoptosis in cancer
Altieri, D. C. (2003) · Oncogene · doi:10.1038/sj.onc.1207113 · Cited by 899 · see citing works
Adapting liposomes for oral drug delivery
He, H., Lu, Y., Qi, J., Zhu, Q., Chen, Z., & Wu, W. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.06.005 · Cited by 663 · see citing works
Naor, D., Nedvetzki, S., Golan, I., Мельник, Л. В., & Faitelson, Y. (2002) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360290795574 · Cited by 557 · see citing works
Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance
Devarajan, E., Şahin, A. A., Chen, J. S., Krishnamurthy, R. R., Aggarwal, N., Brun, A.-M., Sapino, A., Zhang, F., Sharma, D., Yang, X.-H., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1206044 · Cited by 466 · see citing works
Development and application of hyaluronic acid in tumor targeting drug delivery
Luo, Z., Dai, Y., & Gao, H. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.06.004 · Cited by 390 · see citing works
Krauss, A. C., Gao, X., Li, L., Manning, M. L., Patel, P., Fu, W., Janoria, K. G., Gieser, G., Bateman, D. A., Przepiorka, D., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2990 · Cited by 336 · see citing works
How to Stabilize Phospholipid Liposomes (Using Nanoparticles)
Zhang, L., & Granick, S. (2006) · Nano Letters · doi:10.1021/nl052455y · Cited by 278 · see citing works
Influencing factors and strategies of enhancing nanoparticles into tumors in vivo
Zhang, M., Gao, S., Yang, D., Fang, Y., Lin, X., Jin, X., Liu, Y., Liu, X., Su, K., & Shi, K. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.033 · Cited by 277 · see citing works
Lv, Y., Xu, C., Zhao, X., Lin, C., Yang, X., Xin, X., Zhang, L., Qin, C., Han, X., Yang, L., et al. (2018) · ACS Nano · doi:10.1021/acsnano.7b08051 · Cited by 235 · see citing works
Self-citationRoles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer
Karousou, E. G., Misra, S., Ghatak, S., Dobra, K., Götte, M., Vigetti, D., Passi, A. G., Karamanos, N. K., & Skandalis, S. S. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.10.001 · Cited by 202 · see citing works
pH-Sensitive nanoscale materials as robust drug delivery systems for cancer therapy
Shi, Z., Li, Q., & Mei, L. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.03.001 · Cited by 188 · see citing works
Liposome-based delivery of biological drugs
Magar, K. T., Boafo, G. F., Li, X., Chen, Z., & He, W. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.08.020 · Cited by 185 · see citing works
Self-citationSize and surface charge significantly influence the toxicity of silica and dendritic nanoparticles
Greish, K. F., Thiagarajan, G., Gustafson, H. H., Price, R., Bauer, H., Hubbard, D., Burckle, A. J., Sadekar, S., Tian, Y., Anwar, A., et al. (2011) · Nanotoxicology · doi:10.3109/17435390.2011.604442 · Cited by 166 · see citing works
Caspase‐3: A primary target for natural and synthetic compounds for cancer therapy
Yadav, P., Yadav, R., Jain, S., & Vaidya, A. (2021) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13860 · Cited by 156 · see citing works
Delivery strategies of amphotericin B for invasive fungal infections
Wang, X., Mohammad, I. S., Fan, L., Zhao, Z., Nurunnabi, M., Sallam, M. A., Wu, J., Chen, Z., Yin, L., & He, W. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.010 · Cited by 149 · see citing works
Self-citationEvaluating the Efficiency of Hyaluronic Acid for Tumor Targeting via CD44
Spadea, A., Rosa, J. M. R. D. L., Tirella, A., Ashford, M. B., Williams, K. J., Stratford, I. J., Tirelli, N., & Mehibel, M. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00083 · Cited by 147 · see citing works
The progress and perspective of strategies to improve tumor penetration of nanomedicines
Hu, J., Yuan, X., Wang, F., Gao, H., Liu, X., & Zhang, W. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.11.006 · Cited by 144 · see citing works
Nanobowl-Supported Liposomes Improve Drug Loading and Delivery
Chen, Z., Yang, S., Liu, X., Gao, Y., Dong, X., Lai, X. P., Zhu, M., Feng, H., Zhu, X., Lu, Q., et al. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c00495 · Cited by 129 · see citing works
Advances in aggregatable nanoparticles for tumor-targeted drug delivery
Yu, W., Shevtsov, M. A., Chen, X., & Gao, H. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.02.036 · Cited by 123 · see citing works
Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: In vitro and in vivo studies
Zhang, H., Wang, J., Mao, W., Huang, J., Wu, X., Shen, Y., & Sui, M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.019 · Cited by 110 · see citing works
When liposomes met antibodies: Drug delivery and beyond
Di, J., Xie, F., & Xu, Y. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.09.003 · Cited by 107 · see citing works
Wang, S., Zhong, Z., Wan, J., Tan, W., Wu, G., Chen, M., & Wang, Y. (2013) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x13500134 · Cited by 106 · see citing works
Self-citationOridonin inhibits breast cancer growth and metastasis through blocking the Notch signaling
Xia, S., Zhang, X., Li, C., & Guan, H. (2017) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2017.04.037 · Cited by 70 · see citing works
Cytotoxic and Antitumor Activities ofRabdosiaDiterpenoids
Fujita, T., Takeda, Y., Sun, H., Minami, Y., Marunaka, T., Takeda, S., Yamada, Y., & Togo, T. (1988) · Planta Medica · doi:10.1055/s-2006-962485 · Cited by 65 · see citing works
Wang, Y., Wu, Q., Wang, J., Li, L., Sun, X., Zhang, Z., & Zhang, L. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.024 · Cited by 65 · see citing works
Self-citationCadete, A., & Alonso, M. J. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0117 · Cited by 63 · see citing works
Luo, D., Yi, Y., Peng, K., Liu, T., Yang, J., Liu, S., Zhao, W., Qu, X., Yu, W., Gu, Y., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.06.006 · Cited by 57 · see citing works
Intracellular codelivery of anti-inflammatory drug and anti-miR 155 to treat inflammatory disease
Teng, C., Lin, C., Huang, F., Xing, X., Chen, S., Ye, L., Azevedo, H. S., Xu, C., Wu, Z., Chen, Z., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.06.005 · Cited by 50 · see citing works
Self-citationDu, X., Hou, Y., Huang, J., Pang, Y., Ruan, C., Wu, W., Xu, C., Zhang, H., Yin, L., & He, W. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.014 · Cited by 44 · see citing works
Self-citationZhao, Y., Foster, N. R., Meyers, J. P., Thomas, S. P., Northfelt, D., Rowland, K. M., Mattar, B. I., Johnson, D. B., Molina, J. R., Mandrekar, S. J., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000383 · Cited by 43 · see citing works
Milinkovic, M. V., Antin, J. H., Hergrueter, C. A., Underhill, C. B., & Sackstein, R. (2003) · Blood · doi:10.1182/blood-2003-05-1500 · Cited by 40 · see citing works
Cao, S., Huang, Y., Zhang, Q., Lu, F., Donkor, P. O., Zhu, Y., Qiu, F., & Kang, N. (2018) · APOPTOSIS · doi:10.1007/s10495-018-1497-0 · Cited by 27 · see citing works
Vántus, T., Vertommen, D., Saelens, X., Rykx, A., Kimpe, L. D., Vancauwenbergh, S., Mikhalap, S. V., Waelkens, E., Kéri, G., Seufferlein, T. T. W., et al. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2003.11.009 · Cited by 25 · see citing works
Martin, S., Wang, H., Rathke, T., Anderegg, U., Möller, S., Schnabelrauch, M., Pompe, W., & Schmidt, S. (2016) · Polymer · doi:10.1016/j.polymer.2016.02.019 · Cited by 19 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Smart nanoparticles for cancer therapy
Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073 · see citing works
Multifunctional nanoparticle-mediated combining therapy for human diseases
Li, X., Peng, X., Zoulikha, M., Boafo, G. F., Magar, K. T., Ju, Y., & He, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01668-1 · Cited by 546 · see citing works
Self-citationSolubilization techniques used for poorly water-soluble drugs
Xie, B., Liu, Y., Li, X., Yang, P., & He, W. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.08.027 · Cited by 230 · see citing works
Self-citationRecent Advances in Lipid Nanoparticles for Delivery of mRNA
Yang, L., Gong, L., Wang, P., Zhao, X., Zhao, F. H., Zhang, Z., Li, Y., & Huang, W. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122682 · Cited by 178 · see citing works
Approved Nanomedicine against Diseases
Jia, Y., Jiang, Y., He, Y., Zhang, W., Zou, J., Magar, K. T., Boucetta, H., Teng, C., & He, W. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030774 · Cited by 169 · see citing works
Self-citationLipid carriers for mRNA delivery
Zhang, W., Jiang, Y., He, Y., Boucetta, H., Wu, J., Chen, Z., & He, W. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.11.026 · Cited by 130 · see citing works
Self-citationNing, S., Zhang, T., Lyu, M., Lam, J. W. Y., Zhu, D., Huang, Q., & Tang, B. Z. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122034 · Cited by 79 · see citing works
Gout therapeutics and drug delivery
Peng, X., Li, X., Xie, B., Lai, Y., Sosnik, A., Boucetta, H., Chen, Z., & He, W. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.011 · Cited by 75 · see citing works
Self-citationNano and microcomposites as gamma and X-ray ionizing radiation shielding materials — A review
Sobczak, J., & Żyła, G. (2024) · Energy · doi:10.1016/j.energy.2023.130210 · Cited by 64 · see citing works
He, Y., Zhang, W., Xiao, Q., Fan, L., Huang, D., Chen, W., & He, W. (2022) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2022.11.002 · Cited by 53 · see citing works
Self-citationLi, X., Li, J., Wei, J., Du, W., Su, C., Shen, X., Zhao, A., & Xu, M. (2025) · MedComm · doi:10.1002/mco2.70414 · Cited by 56 · see citing works
Self-citationDrug Delivery and Therapy Strategies for Osteoporosis Intervention
Ma, M., Zeng, H., Yang, P., Xu, J., Zhang, X., & He, W. (2023) · Molecules · doi:10.3390/molecules28186652 · Cited by 40 · see citing works
Self-citationBio-nanomaterials: Promising anticancer properties and treatment strategies
Elemike, E. E., Onunkwo, I. C., Ughumiakpor, O., Alawuru, F., Mukoro, A., Ishom, P., Obarakpor, F., Hossain, I., & Aziza, A. E. (2025) · Nano TransMed · doi:10.1016/j.ntm.2025.100076 · Cited by 41 · see citing works
Recent advances in biomedical applications of smart nanomaterials: a comprehensive review
Goshisht, M. K., Goshisht, A., Bajpai, A., & Bajpai, A. (2025) · RSC Pharmaceutics · doi:10.1039/d5pm00137d · Cited by 35 · see citing works
COVID-19 inflammation and implications in drug delivery
Zoulikha, M., Huang, F., Wu, Z., & He, W. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.04.027 · Cited by 30 · see citing works
Self-citationBoucetta, H., Zhang, L., Sosnik, A., & He, W. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.11.012 · Cited by 26 · see citing works
Self-citationDrug delivery for platinum therapeutics
Liu, H., Zou, J., Li, X., Ge, Y., & He, W. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.02.006 · Cited by 25 · see citing works
Self-citationZhou, P., Chao, Q., Li, C., Wang, N., Guo, S., Wang, P., Ge, P., Li, C., Guo, R., Yang, N., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03385-z · Cited by 25 · see citing works
Self-citationPaclitaxel-lipid prodrug liposomes for improved drug delivery and breast carcinoma therapy
Wu, X. Y., Chen, X., Wang, X., Chen, X., Chen, J., & Wu, W. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.108756 · Cited by 19 · see citing works
CAR-T cells for cancer immunotherapy
Xie, Y., Li, X., Wu, J., Zeng, H., Boucetta, H., Wang, B., Yang, P., & He, W. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.108202 · Cited by 18 · see citing works
Self-citationEngineered organic nanoparticles to combat biofilms
Sheng, Y., Chen, Z., Wu, W., & Lü, Y. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103455 · Cited by 17 · see citing works
Cao, X., Yang, C., Zhu, X., Zhao, M., Yan, Y., Huang, Z., Cai, J., Zhuang, J., Li, S., Li, W., et al. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.109199 · Cited by 17 · see citing works
Oral Delivery Strategies for Biological Drugs
Zeng, H., Ma, M., Peng, X., Xie, Y., Xie, A., Deng, B., Ouyang, J., Tao, W., Yang, P., & He, W. (2025) · Small Methods · doi:10.1002/smtd.202401355 · Cited by 17 · see citing works
Self-citationResearch Progress on Gene Synthesis and Anticancer and Lipid-lowering Mechanism of Monacolin K
Sun, Q.-W., & Hong, H.-S. (2023) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520623666230207122157 · Cited by 9 · see citing works
Li, J., An, Y., Wang, M., & Li, D. (2024) · Chinese Journal of Analytical Chemistry · doi:10.1016/j.cjac.2024.100400 · Cited by 5 · see citing works
Xi, X. I. E., Shan, Y., ZHANG, X., Wu, Y., & Liao, J. (2022) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2022-0428 · Cited by 4 · see citing works
Therapeutic liposomes synergize with active molecules to enhance targeted therapy
Partoazar, A., Goudarzi, R., & Dehpour, A. R. (2025) · Journal of drug targeting · doi:10.1080/1061186x.2025.2533336 · Cited by 3 · see citing works
Pure drug nanomedicines - where we are?
Lai, Y., Xie, B., Zhang, W., & He, W. (2025) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(25)60851-x · Cited by 3 · see citing works
Self-citationSahoo, G. P., Rajwar, T. K., Halder, J., Mishra, A. K., Mahanty, R., Saha, I., Satpathy, B., Sahoo, R. K., Pradhan, D., Kumar, V., et al. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111797 · Cited by 3 · see citing works
Tripathi, A., Vaishnaw, B., Jaishwal, P., Samal, P. K., Verma, A., & Singh, N. (2025) · Current Materials Science · doi:10.2174/0126661454366845250618053301 · Cited by 2 · see citing works
Ye, J., Hu, T., Wu, Y., Chen, H., Qiu, Q., Geng, R., Ding, H., & Zhao, X. (2022) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2022.3423 · Cited by 1 · see citing works
A Review of the Applications of Vitamin C to Treat Human Diseases
He, X., Zhang, W., He, Y., Jiang, Y., Xu, J., & He, W. (2024) · Pharmaceutical Fronts · doi:10.1055/s-0044-1791542 · Cited by 1 · see citing works
Self-citationJu, J., Wu, Y., He, W., Zhan, L., Yin, X., Zhang, J. J., Zhang, Y., Li, Q., Muhammad, P., Reis, R. L., et al. (2022) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2022.3446 · Cited by 1 · see citing works
Self-citationDai, F., Chen, W., Li, H., Deng, R., Wang, Y., & Yang, J. (2022) · Materials Express · doi:10.1166/mex.2022.2262
Self-citationShen, Y., Ni, S., Liu, Y., Li, S., Mo, D., & Lv, B. (2022) · Materials Express · doi:10.1166/mex.2022.2268
Anticancer effect of miR-124-loaded liposomal nanoparticles on pancreatic cancer progression
Bian, W., Ma, J., Wang, H., Dai, T., & Zhou, Y. (2023) · Materials Express · doi:10.1166/mex.2023.2347
Li, H., Xu, L., Li, M., & Gao, Z. (2023) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2023.3519
Future trends in LNP-mRNA therapeutics
Singh, A. K., Singh, B., & Mishra, S. B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45006-8.00014-8
- Authors
- Xiao, Q., Li, X., Liu, C., Yang, Y., Hou, Y., Wang, Y., Su, M., & He, W.
- Affiliations
- China Pharmaceutical University (CN)
- Corresponding author
- Su, Mengxiang
- He, Wei
- Venue
- Chinese Chemical Letters
- Publisher
- Elsevier BV
- Published
- 2022-09
- Volume
- 33
- Issue
- 9
- Pages
- 4191-4196
- ISSN
- 1001-8417 (ISSN-L)
- OpenAlex
- W4210434263
- Cited by
- 38
- References
- 40
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 4 · 2023: 13 · 2022: 10
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chinese Chemical Letters (publishedVersion)
- Funders
- National Natural Science Foundation of China
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- caspase-3, oridonin, hyaluronic acid, CD44 targeting, targeted drug delivery, co-delivery, apoptosis, tumor growth inhibition, 4T1 cells, synergistic cancer therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review